About Chugai Pharmaceutical
Chugai Pharmaceutical is a company based in Tokyo (Japan) founded in 1925 was acquired by Roche in October 2006. Chugai Pharmaceutical has completed 1 acquisition, including Renalys.
- Headquarter Tokyo, Japan
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Chugai Pharma Usa, Inc.
-
Annual Revenue
$8.04 B (USD)7.46as on Dec 31, 2025
-
Net Profit
$2.77 B (USD)12.06as on Dec 31, 2025
-
EBITDA
$3.97 B (USD)8.19as on Dec 31, 2025
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Roche
(Oct 01, 2006)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Chugai Pharmaceutical
Unlock access to complete
Unlock access to complete
Funding Insights of Chugai Pharmaceutical
Detailed funding history for Chugai Pharmaceutical
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Chugai Pharmaceutical
Chugai Pharmaceutical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Roche.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
Locked | Locked | Locked |
Investor details for Chugai Pharmaceutical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chugai Pharmaceutical
Chugai Pharmaceutical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Renalys.
Investment portfolio details for Chugai Pharmaceutical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for renal diseases are developed and launched by Renalys.
|
Locked | Locked | 2023 | Locked |
Complete acquisition details for Chugai Pharmaceutical
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Chugai Pharmaceutical
Detailed financials for Chugai Pharmaceutical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chugai Pharmaceutical Comparisons
Peer comparison for Chugai Pharmaceutical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chugai Pharmaceutical
Detailed competitors of Chugai Pharmaceutical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chugai Pharmaceutical
Complete news archive for Chugai Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chugai Pharmaceutical
Chugai Pharmaceutical was founded in 1925.
Chugai Pharmaceutical is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Tatsuro Kosaka is the current CEO of Chugai Pharmaceutical.
Annual revenue of Chugai Pharmaceutical is $8.04B as on Dec 31, 2025.
Chugai Pharmaceutical was founded in 1925 and is headquartered in Tokyo, Japan, within the pharmaceutical sector. Research and development efforts are centered on creating medications for various health needs. Operations include collaborative partnerships to combine expertise in treatment creation and delivery. Patient-centric approaches are emphasized, alongside sustainable healthcare practices. Contributions are made to scientific progress and global health initiatives through these activities.
Chugai Pharmaceutical has made 1 acquisition, including Renalys.
Chugai Pharmaceutical has 1 investor. Key investors include Roche.